Research

Leiomyosarcoma Lifeline

1-866-912-2730

Newly diagnosed with LMS? Call us for help navigating this new journey.

Caregivers are encouraged to call us too!

SHOW YOUR LOVE

In the month of February, show your love by making a donation! Top 3 donors (of at least $1,000 or more) win a travel package to Miami for our LMS Conference on March 7, 2020.

DONATE NOW

LMSDR is thrilled to continue our partnership with the Broad Institute of MIT & Harvard. *WATCH* the video to learn more about The Broad’s Rare Cancer Dependency Map Initiative, which includes LMS tumors.

New therapies for LMS tumors can’t be discovered until we systematically map the best drug targets. The Rare Cancer Dependency Map Initiative is creating patient models from living tissue and using CRISPR/drug data to help researchers worldwide solve this challenge, together.

New book by LMS patient Bruce Stevens – 100% proceeds go to LMSDR

Choose to Trust: Faith and Pragmatism tackling Cancer

Whether as a patient or a family member, the chances are everyone will be faced with cancer at some stage in their life. Bruce shares his journey of tackling cancer warts and all, from the challenge of telling people through to coming to grips with losing control. He also explores how his Christian faith intersects with this health crisis. If you find yourself in this situation, this will really help you grapple with practical issues.

LMSDR JOINS NCI’s MyPart Program

Creating a bridge between patients and researchers

In the MyPART network, NCI’s mission is to engage patients as partners in rare tumor research. LMSDR is a critical bridge between patients and researchers, helping share experiences and expertise between these important stakeholders.

Rare Tumor Workshops and provide input on research issues important to LMS. We will also share MyPart clinical trials, research opportunities and news, so that you can get involved LMSDR will participate inand provide input on research issues important to LMS. We will also share MyPart clinical trials,and news, so that you can get involved

If you are a young adult or have a child with LMS, you can contribute to the Natural History Study of Rare Solid Tumors. You can help the researchers learn about LMS and how to best help us. Participate!with LMS, you can contribute to theYou can help the researchers learn about LMS and how to best help us.

Sharon & David explain who LMSDR is and what they have accomplished

Grant Awards for LMS Research 2020

$150,000 second year funding SARC for their continued work on looking at new targets for LMS, including the role of TP53, pten, p13K and mTOR. $100,000 to Matt van de Rijn to create a blood test to distinguish leiomyosarcoma from benign uterine fibroids. This is a two-year project. Read about past years awards here: https://lmsdr.org/grant-awards/

Having Surgery? Donate fresh live tumor for researchers!

LMS Blood Drive Update

The leiomyosarcoma blood drive has been a success; over 167 samples have been collected for the circulating DNA research project. The project is spearheaded by Dr. Kristen Ganjoo and Dr. Matt van de Rijn of Stanford University, whose objective is to identify whether a treatment is working or not by looking for tumor DNA in the patient’s blood. This could potentially help patients long before they get their next CT scan. The second goal of the project is to determine if a uterine fibroid is a leiomyosarcoma tumor. Thank you, to all LMS blood donors!